53 related articles for article (PubMed ID: 25591590)
21. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
Wang XS; Liu MZ; Zhang CQ; Cai L; Cui NJ
Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915
[TBL] [Abstract][Full Text] [Related]
22. Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis.
Ye Z; Zhao H; Zhou W; Ye T; Geng C; Li X; Yuan L; Du M; Xu H; Wang Q
Onco Targets Ther; 2020; 13():12857-12866. PubMed ID: 33364781
[TBL] [Abstract][Full Text] [Related]
23. A Potential Biomarker of Dynamic Change in Peripheral CD45RA
Sakuma M; Mimura K; Nakajima S; Kaneta A; Kikuchi T; Nirei A; Tada T; Hanayama H; Okayama H; Sakamoto W; Saito M; Momma T; Saze Z; Kono K
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509302
[TBL] [Abstract][Full Text] [Related]
24. Telomerase in Acute Myeloid Leukemia: A Molecular Update on Diagnosis, Prognosis, and Treatment.
Fonseka LN; Tirado CA
J Assoc Genet Technol; 2016; 42(3):105-10. PubMed ID: 27606805
[TBL] [Abstract][Full Text] [Related]
25. miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts.
Tanaka K; Miyata H; Sugimura K; Fukuda S; Kanemura T; Yamashita K; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Wada H; Nakajima K; Takiguchi S; Mori M; Doki Y
Carcinogenesis; 2015 Aug; 36(8):894-903. PubMed ID: 26026166
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer.
Zhao G; Liu L; Zhao T; Jin S; Jiang S; Cao S; Han J; Xin Y; Dong Q; Liu X; Cui J
Tumour Biol; 2015 May; 36(5):3693-701. PubMed ID: 25725584
[TBL] [Abstract][Full Text] [Related]
27. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
[TBL] [Abstract][Full Text] [Related]
28. Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.
Mukherjee S; Shelar B; Krishna S
Am J Transl Res; 2022; 14(1):20-54. PubMed ID: 35173828
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-24 in Cancer: A Double Side Medal With Opposite Properties.
Wang S; Liu N; Tang Q; Sheng H; Long S; Wu W
Front Oncol; 2020; 10():553714. PubMed ID: 33123467
[TBL] [Abstract][Full Text] [Related]
30. The crucial choice of reference genes: identification of miR-191-5p for normalization of miRNAs expression in bone marrow mesenchymal stromal cell and HS27a/HS5 cell lines.
Costé É; Rouleux-Bonnin F
Sci Rep; 2020 Oct; 10(1):17728. PubMed ID: 33082452
[TBL] [Abstract][Full Text] [Related]
31. Deregulated miRNAs in osteoporosis: effects in bone metastasis.
Bellavia D; Salamanna F; Raimondi L; De Luca A; Carina V; Costa V; Alessandro R; Fini M; Giavaresi G
Cell Mol Life Sci; 2019 Oct; 76(19):3723-3744. PubMed ID: 31147752
[TBL] [Abstract][Full Text] [Related]
32. Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma.
Maghsudlu M; Farashahi Yazd E; Amiriani T
J Gastrointest Cancer; 2020 Mar; 51(1):227-233. PubMed ID: 31020570
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis.
Yao C; Liu HN; Wu H; Chen YJ; Li Y; Fang Y; Shen XZ; Liu TT
J Cancer; 2018; 9(16):2876-2884. PubMed ID: 30123356
[No Abstract] [Full Text] [Related]
34. Recent Advances in Understanding Cholangiocarcinoma.
Kennedy L; Hargrove L; Demieville J; Francis N; Seils R; Villamaria S; Francis H
F1000Res; 2017; 6():1818. PubMed ID: 29067165
[TBL] [Abstract][Full Text] [Related]
35. miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.
Ehrlich L; Hall C; Venter J; Dostal D; Bernuzzi F; Invernizzi P; Meng F; Trzeciakowski JP; Zhou T; Standeford H; Alpini G; Lairmore TC; Glaser S
Am J Pathol; 2017 Mar; 187(3):570-580. PubMed ID: 28087162
[TBL] [Abstract][Full Text] [Related]
36. Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma.
Komatsu S; Ichikawa D; Kawaguchi T; Takeshita H; Miyamae M; Ohashi T; Okajima W; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Oncotarget; 2016 Sep; 7(38):62034-62048. PubMed ID: 27566562
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency.
Fong LY; Taccioli C; Jing R; Smalley KJ; Alder H; Jiang Y; Fadda P; Farber JL; Croce CM
Oncotarget; 2016 Mar; 7(10):10723-38. PubMed ID: 26918602
[TBL] [Abstract][Full Text] [Related]
38. The role of microRNA in esophageal squamous cell carcinoma.
Harada K; Baba Y; Ishimoto T; Shigaki H; Kosumi K; Yoshida N; Watanabe M; Baba H
J Gastroenterol; 2016 Jun; 51(6):520-30. PubMed ID: 26794004
[TBL] [Abstract][Full Text] [Related]
39. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
40. Data Normalization Strategies for MicroRNA Quantification.
Schwarzenbach H; da Silva AM; Calin G; Pantel K
Clin Chem; 2015 Nov; 61(11):1333-42. PubMed ID: 26408530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
